DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20212168

Antenatal rescue corticosteroids and perinatal outcome

Nishat Ahtar, Parul Singh, Naghma Shahrukh, Aleena Haider

Abstract


Background: Antenatal corticosteroids (ACS) is one of the most effective intervention for prevention of neonatal complications in preterm babies. However, due to its transient effects, single repeat course is recommended. This rescue course of ACS is believed to improve feto-maternal outcome in women with preterm labor and was the subject matter of this study.

Methods: Total 200 antenatal women who were admitted for threatened preterm labor, between 28 to 34 weeks of gestation, who had already received a single course of ACS within 7-14 days were allocated into group A and group B. Group A included 100 women, who were given rescue course of ACS. Group B included 100 women who rescue course was not given.

Results: Out of 115 babies in group A and 114 babies in group B, 18 babies (16%) in group A and 30 babies (26%) in group B had NICU admission (p<0.05). Eight babies (6%) in group A and 23 babies (20%) in group B were diagnosed with respiratory distress syndrome (RDS) where the difference was statistically highly significant (p<0.001). Maternal outcome was similar among both the groups.

Conclusions: A single repeat rescue course of ACS helps to improve neonatal outcome in preterm babies.


Keywords


Antenatal corticosteroids, Respiratory distress syndrome, Preterm labor

Full Text:

PDF

References


Hallman M. The story of antenatal steroid therapy before preterm birth. Neonatology. 2015;107(4):352-7.

National Institutes of Health Consensus Conference Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 1995;273(5):413-8.

Carlo WA, McDonald SA, Fanaroff AA, Vohr BR, Stoll BJ, Ehrenkranz RA, et al. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks gestation. JAMA. 2011;306(21):2348-58.

Chawla S, Natarajan G, Rane S, Thomas R, Cortez J, Lua J. Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroids exposure. J Perinat Med. 2010;38(4):419-23.

Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3(3):004454

Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515-25.

Howie RN, Liggins GC. The New Zealand study of antepartum glucocorticoid treatment in lung development. Farrell PM, eds. Biological and Clinical Perspectives. 2nd ed. Massacheusetts: Academic Press; 1982: 255-65.

Committee on Obstetric Practice. ACOG committee opinion no. 713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130(2):102-9.

McEvoy C, Schilling D, Spitale P, O'Malley J, Bowling S, Durand M. Pulmonary function and outcomes in infants randomized to a rescue course of antenatal steroids. Pediatr Pulmonol. 2017;52(9):1171-8.

Garite TJ, Kurtzman J, Maurel K, Clark R. Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Obstetrix Collaborative Research Network. J Obstet Gynecol. 2009;201:428.

Mazumder P, Dutta S, Kaur J, Narang A. Single versus multiple courses of antenatal betamethasone and neonatal outcome: A randomized controlled trial. Indian Pediatr. 2008;45(8):661-7.

Crowther CA, Middleton PF, Voysey M, Askie L, Zhang S, Martlow TK, et al. Effects of repeat prenatal corticosteroids given to women at risk of preterm birth: an individual participant data meta-analysis. PLoS Med. 2019;16(4):1002771.